期刊文献+
共找到2篇文章
< 1 >
每页显示 20 50 100
Evaluation of Insulin Resistance Indices in Type 2 Diabetic Patients Treated with Different Anti-Diabetic Drugs
1
作者 Mohammad-Ali Ghaffari Seyedeh-Arefeh Payami +3 位作者 Seyed-Peyman Payami damoon ashtary-larky Abdolrahim Nikzamir Ghorban Mohammadzadeh 《Open Journal of Endocrine and Metabolic Diseases》 2016年第2期95-101,共7页
Clinically, determination of insulin resistance is important for diabetic patients. We evaluated the relationship among 20/(fasting C-peptide × fasting plasma glucose), HOMA-IR and QUICKI indices in type 2 diabet... Clinically, determination of insulin resistance is important for diabetic patients. We evaluated the relationship among 20/(fasting C-peptide × fasting plasma glucose), HOMA-IR and QUICKI indices in type 2 diabetic patients. The study included 40 patients with type 2 diabetes. Patients divided into three groups based on their medication: metformin, metformin + glibenclamide and metformin + glitazone. Fasting blood sugar, and lipid profile were measured by enzymatic method, serum insulin, and C-peptide were measured by ELISA method. Insulin resistance was calculated by using of 20/(fasting C-peptide × fasting plasma glucose), HOMA-IR and QUICKI indices. There was no significant relationship between 20/(fasting C-peptide × fasting plasma glucose) index and other parameters in all studied groups except QUICKI in metformin group showed a significant correlation with 20/(fasting C-peptide × fasting plasma glucose) index (r = 0.56 and p = 0.03). There was a significant correlation between HOMA-IR and QUICKI indices in all studied groups. There was no significant relationship between 20/(fasting C-peptide × fasting plasma glucose) index with other clinical parameters. On the other hand, our data strongly suggested a significant correlation between HOMA-IR and QUICKI indices in studied subjects with type 2 diabetes. 展开更多
关键词 Type 2 Diabetes Insulin Resistance HOMA-IR QUICKI 20/(Fasting C-Peptide × Fasting Plasma Glucose)
下载PDF
Phytochemistry,pharmacology,and therapeutic uses of black seed(Nigella sativa) 被引量:5
2
作者 Wesam Kooti Zahra Hasanzadeh-Noohi +2 位作者 Naim Sharafi-Ahvazi Majid Asadl-Samani damoon ashtary-larky 《Chinese Journal of Natural Medicines》 SCIE CAS CSCD 2016年第10期732-745,共14页
Black seed(Nigella sativa) is an annual flowering plant from Ranunculaceae family, native to southwest Asia. This plant has many food and medicinal uses. The use of its seeds and oil is common for treatment of many di... Black seed(Nigella sativa) is an annual flowering plant from Ranunculaceae family, native to southwest Asia. This plant has many food and medicinal uses. The use of its seeds and oil is common for treatment of many diseases, including rheumatoid arthritis, asthma, inflammatory diseases, diabetes and digestive diseases. The purpose of this study was to provide a comprehensive review on the scientific reports that have been published about N. sativa. The facts and statistics presented in this review article were gathered from the journals accessible in creditable databases such as Science Direct, Medline, Pub Med, Scopus, EBSCO, EMBASE, SID and Iran Medex. The keywords searched in Persian and English books on medicinal plants and traditional medicine, as well as the above reputable databases were "Black seed", "Nigella sativa", "therapeutic effect", and "medicinal plant". The results showed that N. sativa has many biological effects such as anti-inflammatory, anti-hyperlipidemic, anti-microbial, anti-cancer, anti-oxidant, anti-diabetic, anti-hypertensive, and wound healing activities. It also has effects on reproductive, digestive, immune and central nervous systems, such as anticonvulsant and analgesic activities. In summary, it can be used as a valuable plant for production of new drugs for treatment of many diseases. 展开更多
关键词 Nigella sativa Black seed Medicinal plant ETHNOPHARMACOLOGY PHYTOTHERAPY
原文传递
上一页 1 下一页 到第
使用帮助 返回顶部